Multi-Jurisdictional Moldx: Molecular Testing For Risk Stratification of Upper Gastrointestinal Cancer Contractor Advisory Committee (CAC): October 12, 2021

Published 11/22/2021

Palmetto GBA, CGS Administrators, Noridian Healthcare Solutions and WPS Government Health Administrators hosted a Multi-Jurisdictional Contractor Advisory Committee (CAC) Meeting via teleconference on October 12, 2021, from 2 to 4 p.m. ET. Discussions focused on MolDX: Molecular Testing for Risk Stratification of Upper Gastrointestinal Cancer.

The Centers for Medicare & Medicaid Services (CMS) assigns Medicare Administrative Contractors (MACs) the task of developing Local Coverage Determinations (LCDs). The purpose of the CAC meeting is to provide a formal mechanism for healthcare professionals to be informed of the evidence used in developing the LCD and promote communications between the MAC and the healthcare community. The CAC panel discussed the clinical literature related to MolDX: Molecular Testing for Risk Stratification of Upper Gastrointestinal Cancer and rate their confidence in a series of key questions. Discussions occurred between CAC panelists and Contractor Medical Directors. The public was able to attend; however, questions from the public were not entertained. 

Meeting Material


Was this article helpful?